CIK 0000883984
- Large accelerated filer
ICU MEDICAL INC/DE
Sign in to watch- Ticker
- ICUI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330022692
- Phone
- +1 949-366-2183
- Business address
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,859,904
- in 4 filings, $3.5M under 10b5-1 plans
Net −$3,859,904. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-12 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −30,000 | $180.02 | $5.4M | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −6,712 | $185.73 | $1.2M | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,637 | $186.50 | $678K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −2,781 | $187.43 | $521K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −8,163 | $188.52 | $1.5M | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −785 | $189.32 | $149K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,699 | $190.48 | $324K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,601 | $192.06 | $307K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −2,418 | $194.02 | $469K | 25,781 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −100 | $194.73 | $19K | 25,781 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −2,104 | $193.30 | $407K | 23,677 |
| 2023-06-07 | FINNEY ELISHA W Director | Sale 10b5-1 | −194 | $190.41 | $37K | 1,481 |
| 2023-04-11 | Sanzone Virginia Ruth VP, General Counsel | Sale 10b5-1 | −250 | $175.00 | $44K | 4,678 |
| 2023-04-05 | Sanzone Virginia Ruth VP, General Counsel | Sale 10b5-1 | −458 | $170.00 | $78K | 4,928 |
| 2023-02-02 | Woolson Daniel VP, GM-Infusion Capital | Sale | −1,731 | $200.00 | $346K | 9,152 |
| 2022-11-15 | Sanzone Virginia Ruth VP, General Counsel | Sale | −325 | $160.12 | $52K | 3,046 |
| 2022-05-12 | Sanzone Virginia Ruth VP, General Counsel | Sale | −750 | $173.56 | $130K | 3,371 |
| 2022-05-12 | FINNEY ELISHA W Director | Sale | −217 | $170.53 | $37K | 1,933 |
| 2022-03-03 | Jain Vivek Chairman and CEO | Sale | −36,000 | $240.00 | $8.6M | 12,779 |
| 2021-12-30 | Jain Vivek Chairman and CEO | Sale | −1,159 | $240.00 | $278K | 12,779 |
Page 5 of 15 · 282 trades